Mergers & Acquisitions ·
Teleflex Incorporated filed an amendment to its August 3, 2026 Form 8-K to include unaudited pro forma financial…
TFXTeleflex Inc
Teleflex Incorporated filed an amendment to its August 3, 2026 Form 8-K to include unaudited pro forma financial information required under Item 9.01(b) following the completion of the sale of its Original Equipment Manufacturing and Development Services business to Lotus US Bidco Inc. The transaction closed on August 3, 2026, generating net cash proceeds of $1.5 billion, or approximately $1.24 billion after-tax, which were used to repay $700 million in debt. The pro forma financials reflect the elimination of the OEM business's assets and liabilities as of March 31, 2026, and its historical results for the year ended December 31, 2025, along with adjustments for ancillary transition agreements. Teleflex is a global provider of medical technology products focused on enhancing clinical benefits and patient safety through single-use medical devices.